Replies to post #338027 on NorthWest Biotherapeutics Inc (NWBO)

[Gus McCrae]

We will discuss this further when the 10Q becomes available.

I love this response, it had me laughing out loud in my office. I assume you meant it in jest, but if you didn't, I assure you I'm not making fun. I also chuckled at HappyLibrarian's original post. I remember once being shocked that a certain company was able to hire a CFO during some particularly turbulent times when it was pretty clear the company had no future. He lasted 4 months before he resigned. What I learned from that, and I've witnessed many other examples over the years, is that someone is always willing to take a C-Level job. Always, always, always. He or she might be a terrible candidate, but there's always a body ready to step up. But, both you and HappyLibrarian's points are well taken.

One thing I take comfort in with NWBO is that they are advised by Gibson Dunn. That's a heavy hitter law firm, especially for a tiny company like NWBO. I'm still super confused about the late 10-Q; things like that should NEVER happen. But, they have very competent counsel, which gives me some level of comfort, rightly or wrongly.

Fun fact: because the company is late on the 10-Q, they will not be able to issue equity under their S-3 after they file their next 10-K. So if they raise money after March 2021, they will have to file an S-1. Not that big of a deal, but still...what I'm getting at is this is a company that isn't acting like it will be here in 4 months. No CFO, warrant exercise suspension, another NT 10-Q, no CMO or other evidence of intent to commercialize, etc...read into that what you will.

[CogDiss 1188X]

My five year old just asked if we could get a dog. I told him “we will discuss this further when the 10Q becomes available.”

Now he wants to know when the 10Q will be available.

Kids these days. Never satisfied.